A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo.

MLA

Liu, Haifeng, et al. “A Potential Strategy against Clinical Carbapenem-Resistant Enterobacteriaceae: Antimicrobial Activity Study of Sweetener-Decorated Gold Nanoparticles in Vitro and in Vivo.” Journal of Nanobiotechnology, vol. 21, no. 1, Nov. 2023, pp. 1–23. EBSCOhost, https://doi.org/10.1186/s12951-023-02149-x.

APA

Liu, H., Huang, Z., Chen, H., Zhang, Y., Yu, P., Hu, P., Zhang, X., Cao, J., & Zhou, T. (2023). A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo. Journal of Nanobiotechnology, 21(1), 1–23. https://doi.org/10.1186/s12951-023-02149-x

Chicago

Liu, Haifeng, Zeyu Huang, Huanchang Chen, Ying Zhang, Pingting Yu, Panjie Hu, Xiaotuan Zhang, Jianming Cao, and Tieli Zhou. 2023. “A Potential Strategy against Clinical Carbapenem-Resistant Enterobacteriaceae: Antimicrobial Activity Study of Sweetener-Decorated Gold Nanoparticles in Vitro and in Vivo.” Journal of Nanobiotechnology 21 (1): 1–23. doi:10.1186/s12951-023-02149-x.